Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 2/2014

01-02-2014 | Letter to the Editor

Screening for Intimate Partner Violence at VA EDs: The Time Is Now

Author: Nancy Lutwak, M.D.

Published in: Journal of General Internal Medicine | Issue 2/2014

Login to get access

Excerpt

To the Editors:—Intimate partner violence is a serious societal problem and contributes significantly to negative health consequences. The recently published editorial by Mitchell D. Feldman focused on this crisis and recommended routine screening by primary care providers. Recent publications have discussed screening for IPV at Veterans Health Administration (VHA) Centers.1 – 3 …
Literature
1.
2.
Sweeney AC, et al. Intimate partner violence: perspectives on universal screening for women in VHA primary care. Women’s Health Issues. 2013;23(2):e73–e76.PubMedCrossRef
3.
4.
Lutwak N, Dill C. Military sexual trauma increases risk of post-traumatic stress disorder and depression thereby amplifying the possibility of suicidal ideation and cardiovascular disease. Mil Med. 2013;178(4):359–61. doi:10.​7205/​MILMED-D-12-00427.PubMedCrossRef
Metadata
Title
Screening for Intimate Partner Violence at VA EDs: The Time Is Now
Author
Nancy Lutwak, M.D.
Publication date
01-02-2014
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 2/2014
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-013-2717-5

Other articles of this Issue 2/2014

Journal of General Internal Medicine 2/2014 Go to the issue

Capsule Commentary

Capsule Commentary on Radin, Pitfalls in Hemoglobin A1c Measurement: When Results May Be Misleading

Erratum

Erratum to: Exploring Public Attitudes Towards Approaches to Discussing Costs in the Clinical Encounter

Healing Arts

Diwali in the HIV Ward

Capsule Commentary

Capsule Commentary on Wilson et al., The Prevalence of Harmful and Hazardous Alcohol Consumption in U.S. Older Adults

OriginalPaper

Capsule Commentary on Yoong et al., A Cross-sectional Study Examining Australian General Practitioners’ Identification of Overweight and Obese Patients

Clinical Image

Acute Aortic Dissection Presenting as Painless Paraplegia
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits